Vaxart
VXRT
#9829
Rank
A$0.13 B
Marketcap
A$0.54
Share price
0.00%
Change (1 day)
-9.99%
Change (1 year)

Earnings for Vaxart (VXRT)

Earnings in 2026 (TTM): A$58.45 Million

According to Vaxart's latest financial reports the company's current earnings are A$0.24 Billion. In 2025 the company made an earning of A$25.24 Million, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vaxart from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$58.45 M131.55%
2025 A$25.24 M-125.2%
2024 -A$0.11 Billion-18.87%
2023 -A$0.13 Billion-23.67%
2022 -A$0.17 Billion53.05%
2021 -A$0.11 Billion120.01%
2020 -A$48.05 Million76.16%
2019 -A$27.28 Million1.44%
2018 -A$26.89 Million-4.29%
2017 -A$28.1 Million-40.06%
2016 -A$46.88 Million-2.19%
2015 -A$47.93 Million319.74%
2014 -A$11.42 Million-25.37%
2013 -A$15.3 Million148.49%
2012 -A$6.16 Million-57.4%
2011 -A$14.46 Million810.89%
2010 -A$1.59 Million-94.36%
2009 -A$28.14 Million5.65%
2008 -A$26.64 Million-59.66%
2007 -A$66.03 Million-18.43%
2006 -A$80.95 Million-58.15%
2005 -A$0.2 Billion221.93%
2004 -A$60.09 Million197.62%
2003 -A$20.19 Million-603.26%
2002 A$4.01 M-97.7%
2001 A$0.17 B2727.95%
2000 A$6.16 M-10.78%
1999 A$6.91 M-177.97%
1998 -A$8.87 Million-62.89%
1997 -A$23.89 Million-284.88%
1996 A$12.92 M-179.63%
1995 -A$16.23 Million-175%
1994 A$21.63 M171.7%
1993 A$7.96 M2550%
1992 A$0.3 M-93.33%
1991 A$4.5 M3.45%
1990 A$4.35 M-80.92%
1989 A$22.83 M985.71%
1988 A$2.1 M7.69%
1987 A$1.95 M-27.78%
1986 A$2.7 M5.88%
1985 A$2.55 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.25 Million-105.54% Bahamas
NRC Health
NRC
A$22.21 M-62.09%๐Ÿ‡บ๐Ÿ‡ธ USA